Birdwatch Note
2023-03-21 21:51:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Neither work for the treatment of Covid-19. A higher dose of ivermectin given for a longer duration still failed to offer any benefit in mild to moderate COVID-19 https://www.medpagetoday.com/meetingcoverage/croi/103231 Hydroxychloroquine does not reduce deaths from COVID-19 https://www.cochrane.org/news/chloroquine-or-hydroxychloroquine-useful-treating-people-covid-19-or-preventing-infection
Written by 6EFCEEF8B2FD28B46A0AC920CAB617AAFD94E40F41CBB21B3427B60CBC26799A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1638271365072445440
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1638297426275495936
- noteId - 1638297426275495936
- participantId -
- noteAuthorParticipantId - 6EFCEEF8B2FD28B46A0AC920CAB617AAFD94E40F41CBB21B3427B60CBC26799A Participant Details
- createdAtMillis - 1679435519176
- tweetId - 1638271365072445440
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Neither work for the treatment of Covid-19. A higher dose of ivermectin given for a longer duration still failed to offer any benefit in mild to moderate COVID-19 https://www.medpagetoday.com/meetingcoverage/croi/103231 Hydroxychloroquine does not reduce deaths from COVID-19 https://www.cochrane.org/news/chloroquine-or-hydroxychloroquine-useful-treating-people-covid-19-or-preventing-infection
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-03-21 21:51:59 UTC (1679435519176) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-22 02:38:34 UTC (1679452714982) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-03-21 18:21:55 -0500 | Rating Details | |
2023-03-21 18:04:06 -0500 | Rating Details | |
2023-03-21 18:00:08 -0500 | Rating Details | |
2023-03-21 17:50:51 -0500 | Rating Details | |
2023-03-21 17:48:44 -0500 | Rating Details | |
2023-03-21 17:12:29 -0500 | Rating Details | |
2023-03-21 17:09:42 -0500 | Rating Details | |
2023-03-22 19:08:06 -0500 | Rating Details | |
2023-03-22 19:05:38 -0500 | Rating Details | |
2023-03-22 15:16:21 -0500 | Rating Details | |
2023-03-22 14:42:39 -0500 | Rating Details | |
2023-03-22 12:22:33 -0500 | Rating Details | |
2023-03-22 11:58:55 -0500 | Rating Details | |
2023-03-22 11:41:19 -0500 | Rating Details | |
2023-03-22 04:21:17 -0500 | Rating Details | |
2023-03-22 00:20:42 -0500 | Rating Details | |
2023-03-21 23:24:54 -0500 | Rating Details | |
2023-03-21 23:02:46 -0500 | Rating Details | |
2023-03-21 22:44:55 -0500 | Rating Details | |
2023-03-21 21:55:34 -0500 | Rating Details | |
2023-03-21 21:48:05 -0500 | Rating Details | |
2023-03-21 21:43:42 -0500 | Rating Details | |
2023-03-21 21:01:22 -0500 | Rating Details | |
2023-03-21 20:55:27 -0500 | Rating Details | |
2023-03-21 20:45:05 -0500 | Rating Details | |
2023-03-21 20:32:15 -0500 | Rating Details | |
2023-03-21 20:19:23 -0500 | Rating Details | |
2023-03-21 20:09:19 -0500 | Rating Details | |
2023-03-21 20:00:30 -0500 | Rating Details | |
2023-03-21 19:37:41 -0500 | Rating Details | |
2023-03-22 20:55:25 -0500 | Rating Details | |
2023-03-22 20:29:50 -0500 | Rating Details | |
2023-03-26 05:51:25 -0500 | Rating Details | |
2023-03-22 12:22:33 -0500 | Rating Details | |
2023-03-21 17:50:51 -0500 | Rating Details | |
2023-03-21 17:09:42 -0500 | Rating Details | |
2023-03-22 04:21:17 -0500 | Rating Details | |
2023-03-21 18:21:55 -0500 | Rating Details | |
2023-03-26 05:51:25 -0500 | Rating Details | |
2023-03-21 18:00:08 -0500 | Rating Details | |
2023-03-21 19:37:41 -0500 | Rating Details | |
2023-03-22 14:42:39 -0500 | Rating Details | |
2023-03-21 18:04:06 -0500 | Rating Details | |
2023-03-22 00:20:42 -0500 | Rating Details | |
2023-03-21 23:02:46 -0500 | Rating Details | |
2023-03-22 11:41:19 -0500 | Rating Details | |
2023-03-21 20:32:15 -0500 | Rating Details | |
2023-03-21 23:24:54 -0500 | Rating Details | |
2023-03-21 21:01:22 -0500 | Rating Details | |
2023-03-22 20:55:25 -0500 | Rating Details | |
2023-03-22 20:29:50 -0500 | Rating Details | |
2023-03-21 21:55:34 -0500 | Rating Details | |
2023-03-22 15:16:21 -0500 | Rating Details | |
2023-03-21 20:55:27 -0500 | Rating Details | |
2023-03-21 21:48:05 -0500 | Rating Details | |
2023-03-21 20:00:30 -0500 | Rating Details | |
2023-03-22 11:58:55 -0500 | Rating Details | |
2023-03-21 20:19:23 -0500 | Rating Details | |
2023-03-21 17:12:29 -0500 | Rating Details | |
2023-03-21 20:45:05 -0500 | Rating Details | |
2023-03-22 19:08:06 -0500 | Rating Details | |
2023-03-21 17:48:44 -0500 | Rating Details | |
2023-03-22 19:05:38 -0500 | Rating Details | |
2023-03-21 20:09:19 -0500 | Rating Details | |
2023-03-21 22:44:55 -0500 | Rating Details | |
2023-03-21 21:43:42 -0500 | Rating Details |